| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996397558803316 |
|
|
Autore |
Bache Arthur <b. 1599 or 1600.> |
|
|
Titolo |
The voyce of the Lord in the Temple, or, A most strange and wonderfull relation of Gods great power, providence, and mercy [[electronic resource] ] : in sending very strange sounds, fires, and a fiery ball into the church of Anthony in Cornwall neere Plimmouth, on Whitsunday last, 1640, to the scorching and astonishing of 14 severall persons who were smitten, and likewise to the great terrour of all the other people then present, being about 200 persons : the truth whereof will be maintained by the oathes of the same persons, having been examined by Richard Carew of Anthony, Esquire, and Arthur Bache, Vicar of Anthony |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Imprinted at London, : By T.P. for Francis Eglesfield, and are to be sold by William Russell Bookeseller in Plimmoth, 1640 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
Thunderstorms - England |
Ball lightning |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Author's statement from p. 4 ("My wife, Elizabeth Bache"). |
Signatures: A-B⁴ C⁴ (-C4, blank?) |
Page 5 numbered 9. |
Reproduction of original in: Harvard University. Library. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910349449203321 |
|
|
Titolo |
The Role of Microstructure in Topical Drug Product Development / / edited by Nigel Langley, Bozena Michniak-Kohn, David W. Osborne |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2019.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (207 pages) |
|
|
|
|
|
|
Collana |
|
AAPS Advances in the Pharmaceutical Sciences Series, , 2210-7371 ; ; 36 |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical technology |
Pharmacy |
Pharmaceutical Sciences/Technology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Part I - Critical Quality Attributes: 1. Rheological Characterization in the Development of Topical Drug Products -- 2. In Vitro Release & Permeation Tests as Critical Quality Attributes in Topical Product Development -- 3. Determination of Particle Size and Microstructure in Topical Pharmaceuticals -- Part II - Role of API and Excipients: 4. Quality Assessment of API in Semisolid Topical Drug Products -- 5. The Role of Excipients in the Microstructure of Topical Semi-solid Drug Products. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Following the Semi-solid Microstructure Workshop sponsored by BASF and hosted by the Rutgers Center for Dermal Research, a pharmaceutical product development working group was formed. The group, known as the Q3 Working Group, selected the following five areas of focus: Particle/Globule Size and Distribution, Viscosity/Rheology/Spreadability, In Vitro Testing, State of API, State of Excipients. A committee was appointed for each of these five areas. The committees were tasked to review the literature, identify best practices, list experimental details required for an independent lab to duplicate the test, and propose scientific studies that may meaningfully advance this specific area of focus. Each committee has a chair (or co-chairs) that are the lead author(s) of the chapter. The Q3 Working Group |
|
|
|
|
|
|
|
|
|
|
members serve as the critical reviewers of each chapter, making suggestions that improve the quality of the document and that make each of the five chapters uniform in scope and content. Pharmaceutical development scientists that formulate topical products (creams, lotions, gels suspensions, foams, etc) and all the allied raw material suppliers, packaging suppliers, contract laboratories including CROs, CMOs and regulators need access to this book. Overall, the topic of semisolid microstructure is of equal importance to the generic pharmaceutical companies (filing Abbreviated New Drug Applications or ANDAs) and pharmaceutical companies filing New Drug Applications (NDAs). In addition to products applied to the skin, hair, and nails, The Role of Microstructure in Topical Drug Product Development crosses over and is essential reading to developers of oral suspensions, ophthalmic ointments and gels, otic suspension, vaginal semisolids and retention enemas. . |
|
|
|
|
|
| |